Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449091) titled 'Adaptability of an Undetectable = Untransmissible Model for HBV' on Feb. 27.

Study Type: Observational

Primary Sponsor: NYU Langone Health

Condition: Chronic Hepatitis b Viremia

Recruitment Status: Not recruiting

Date of First Enrollment: March 2026

Target Sample Size: 55

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07449091

Published by HT Digital Content Services with permission from Health Daily Digest....